U.S. Physical Therapy upgraded by Barrington Research with a new price target
$USPH
Medical/Nursing Services
Health Care
Barrington Research upgraded U.S. Physical Therapy from Mkt Perform to Outperform and set a new price target of $130.00
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 10/7/2024 | $114.00 → $90.00 | Buy → Neutral | BofA Securities |
| 9/22/2023 | $108.00 | Overweight | JP Morgan |
| 6/30/2023 | $138.00 | Buy | BofA Securities |
| 12/14/2021 | $120.00 | Market Perform → Market Outperform | CJS Securities |
| 8/6/2021 | $130.00 → $139.00 | Outperform | Barrington Research |
4 - U S PHYSICAL THERAPY INC /NV (0000885978) (Issuer)
4 - U S PHYSICAL THERAPY INC /NV (0000885978) (Issuer)
U.S. Physical Therapy, Inc. (NYSE:USPH), a national operator of outpatient physical therapy clinics and provider of industrial injury prevention services, announced that it will report its financial results for the three and nine months ended September 30, 2024, on Tuesday, November 5, 2024, after the stock market closes, with the conference call to follow the next morning, on Wednesday, November 6, 2024. Conference Call Date: Wednesday, November 6, 2024 Time: 10:30 am Eastern/9:30 am Central Dial-In Number: (800) 245-3047 Primary or (203) 518-9765 Alternate Conference ID: USPHQ324 (In order to join this conference call, you will be required
U.S. Physical Therapy, Inc. (the "Company") (NYSE:USPH), a national operator of outpatient physical therapy clinics and provider of industrial injury prevention services, announced the acquisition of a physical therapy and hand therapy practice with eight clinic locations located in Pennsylvania which currently generates approximately $5.5 million in annual revenues. The Company acquired a 70% interest in the Company with the current owners retaining a 30% ownership interest. About U.S. Physical Therapy, Inc. Founded in 1990, U.S. Physical Therapy, Inc. operates 687 outpatient physical therapy clinics in 42 states. The Company's clinics provide preventative and post-operative care for a
U.S. Physical Therapy, Inc. (NYSE:USPH), a national operator of outpatient physical therapy clinics and provider of industrial injury prevention services, announced that it will report its financial results for the three and six months ended June 30, 2024, on Tuesday, August 13, 2024, after the stock market closes, with the conference call to follow the next morning, on Wednesday, August 14, 2024. Conference Call Date: Wednesday, August 14, 2024 Time: 10:30 am Eastern/9:30 am Central Dial-In Number: (800) 245-3047 Primary or (203) 518-9765 Alternate Conference ID: USPHQ224 (In order to join this conference call,
U.S. Physical Therapy, Inc. (the "Company) (NYSE:USPH), a national operator of outpatient physical therapy clinics and provider of industrial injury prevention services, today announced that Chris Reading, Chief Executive Officer, will participate in the Stephens Annual Investment Conference on Wednesday, November 20, 2024. On the same day, Carey Hendrickson, Chief Financial Officer, will present at the 16th Annual Southwest IDEAS Conference. The presentations will cover an overview of the Company. About U.S. Physical Therapy, Inc. Founded in 1990, U.S. Physical Therapy, Inc. owns and/or manages 754 outpatient physical therapy clinics in 43 states. USPH clinics provide preventative and
Reports Record Quarterly Patient Volume U.S. Physical Therapy, Inc. ("USPH" or the "Company") (NYSE:USPH), a national operator of outpatient physical therapy clinics and provider of industrial injury prevention services, today reported results for the three and nine months ended September 30, 2024. FINANCIAL HIGHLIGHTS Adjusted EBITDA (1), a non-Generally Accepted Accounting Principles ("GAAP") measure, was $21.1 million for the three months ended September 30, 2024 ("2024 Third Quarter"), an increase of $2.5 million from $18.6 million in the three months ended September 30, 2023 ("2023 Third Quarter"). Operating Results (1), a non-GAAP measure, was $10.4 million in the 2024 Third Qua
U.S. Physical Therapy, Inc. ("USPH") (NYSE:USPH), a national operator of outpatient physical therapy clinics and provider of industrial injury prevention services, closed the previously announced acquisition of a 50% equity interest in a management services organization (the "Company") that provides management and administrative services to 50 outpatient physical therapy clinics, the majority of which are in New York, with plans to further expand in New York and adjacent states. The Company-managed clinics deliver physical, occupational and speech therapy in outpatient clinics, and also provide physical therapy services to patients in their homes. Through its managed therapy providers, the
SC 13G/A - U S PHYSICAL THERAPY INC /NV (0000885978) (Subject)
SC 13G - U S PHYSICAL THERAPY INC /NV (0000885978) (Subject)
SC 13G - U S PHYSICAL THERAPY INC /NV (0000885978) (Subject)
4 - U S PHYSICAL THERAPY INC /NV (0000885978) (Issuer)
4 - U S PHYSICAL THERAPY INC /NV (0000885978) (Issuer)
4 - U S PHYSICAL THERAPY INC /NV (0000885978) (Issuer)
8-K - U S PHYSICAL THERAPY INC /NV (0000885978) (Filer)
8-K - U S PHYSICAL THERAPY INC /NV (0000885978) (Filer)
10-Q - U S PHYSICAL THERAPY INC /NV (0000885978) (Filer)
EAGAN, Minn., June 20, 2023 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ:POAI), a science-driven company leveraging its proprietary artificial intelligence and machine learning capabilities, extensive biorepository of tumor samples, Clinical Laboratory Improvement Amendments (CLIA) laboratory and Good Manufacturing Practices (GMP) facility, to accelerate oncology drug discovery and enable drug development, today announced the appointment of Dr. Bernard A. Harris, Jr. to its newly-formed Business Advisory Board (BAB). "I am very pleased to welcome Dr. Harris to our new Business Advisory Board," said Raymond F. Vennare, Chief Executive Officer of Predictive Oncology. "As we continue
~Highly Esteemed Growth Strategist and Financial Expert with Decades of Business Acumen~ NEW YORK, Oct. 18, 2022 /PRNewswire/ -- The National Kidney Foundation (NKF) is pleased to announce the appointment of Anne Motsenbocker to its national Board of Directors. We're honored & excited Anne has joined the national board to share her extensive business acumen in board governance.Motsenbocker resides in Dallas, Texas and is a former banker and seasoned board member bringing over 35 years of commercial banking and wealth management expertise due to the numerous roles she held at J
HOUSTON, June 10, 2022 /PRNewswire/ -- Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ:NUTX), a physician-led, technology-enabled healthcare services company comprised of a hospital division with 21 facilities in 8 states and a primary care-centric, risk-bearing population health management division, today announced the appointment of Jon Bates as the Company's Chief Financial Officer effective on or about June 30, 2022. On May 3, 2022, Michael Bowen notified the company that he intends to retire as Chief Financial Officer of the Company. In connection with Mr. Bowen's retirement, the Company's Board formed a search committee. On June 8, 2022, the Company announced the appointme
Barrington Research analyst Michael Petusky maintains US Physical Therapy (NYSE:USPH) with a Outperform and maintains $122 price target.
US Physical Therapy (NYSE:USPH) reported quarterly earnings of $0.51 per share which missed the analyst consensus estimate of $0.56 by 8.93 percent. This is a 13.56 percent decrease over earnings of $0.59 per share from the same period last year. The company reported quarterly sales of $155.675 million which beat the analyst consensus estimate of $153.366 million by 1.51 percent. This is a 4.83 percent increase over sales of $148.509 million the same period last year.
BofA Securities downgraded U.S. Physical Therapy from Buy to Neutral and set a new price target of $90.00 from $114.00 previously
JP Morgan initiated coverage of U.S. Physical Therapy with a rating of Overweight and set a new price target of $108.00
BofA Securities initiated coverage of U.S. Physical Therapy with a rating of Buy and set a new price target of $138.00